Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein

Katerina E. Paleologou, Adrian W. Schmid, Carla C. Rospigliosi, Hai Young Kim, Gonzalo R. Lamberto, Ross A. Fredenburg, Peter T. Lansbury, Claudio O. Fernandez, David Eliezer, Markus Zweckstetter, Hilal A. Lashuel

Research output: Contribution to journalArticle

191 Citations (Scopus)

Abstract

α-Synuclein (α-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related α-synulceinopathies. However, whether phosphorylation promotes or inhibits α-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of α-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type α-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated α-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of α-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of α-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern α-syn aggregation and toxicity in PD and related α-synulceinopathies.

Original languageEnglish
Pages (from-to)16895-16905
Number of pages11
JournalJournal of Biological Chemistry
Volume283
Issue number24
DOIs
Publication statusPublished - 13 Jun 2008
Externally publishedYes

Fingerprint

Synucleins
Phosphorylation
Parkinson Disease
Agglomeration
Membranes
Serine
Toxicity
Conformations
Health

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Paleologou, K. E., Schmid, A. W., Rospigliosi, C. C., Kim, H. Y., Lamberto, G. R., Fredenburg, R. A., ... Lashuel, H. A. (2008). Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein. Journal of Biological Chemistry, 283(24), 16895-16905. https://doi.org/10.1074/jbc.M800747200

Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein. / Paleologou, Katerina E.; Schmid, Adrian W.; Rospigliosi, Carla C.; Kim, Hai Young; Lamberto, Gonzalo R.; Fredenburg, Ross A.; Lansbury, Peter T.; Fernandez, Claudio O.; Eliezer, David; Zweckstetter, Markus; Lashuel, Hilal A.

In: Journal of Biological Chemistry, Vol. 283, No. 24, 13.06.2008, p. 16895-16905.

Research output: Contribution to journalArticle

Paleologou, KE, Schmid, AW, Rospigliosi, CC, Kim, HY, Lamberto, GR, Fredenburg, RA, Lansbury, PT, Fernandez, CO, Eliezer, D, Zweckstetter, M & Lashuel, HA 2008, 'Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein', Journal of Biological Chemistry, vol. 283, no. 24, pp. 16895-16905. https://doi.org/10.1074/jbc.M800747200
Paleologou KE, Schmid AW, Rospigliosi CC, Kim HY, Lamberto GR, Fredenburg RA et al. Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein. Journal of Biological Chemistry. 2008 Jun 13;283(24):16895-16905. https://doi.org/10.1074/jbc.M800747200
Paleologou, Katerina E. ; Schmid, Adrian W. ; Rospigliosi, Carla C. ; Kim, Hai Young ; Lamberto, Gonzalo R. ; Fredenburg, Ross A. ; Lansbury, Peter T. ; Fernandez, Claudio O. ; Eliezer, David ; Zweckstetter, Markus ; Lashuel, Hilal A. / Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein. In: Journal of Biological Chemistry. 2008 ; Vol. 283, No. 24. pp. 16895-16905.
@article{7bacd249a7264fb897e0e51c81be32be,
title = "Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein",
abstract = "α-Synuclein (α-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related α-synulceinopathies. However, whether phosphorylation promotes or inhibits α-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of α-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type α-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated α-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of α-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of α-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern α-syn aggregation and toxicity in PD and related α-synulceinopathies.",
author = "Paleologou, {Katerina E.} and Schmid, {Adrian W.} and Rospigliosi, {Carla C.} and Kim, {Hai Young} and Lamberto, {Gonzalo R.} and Fredenburg, {Ross A.} and Lansbury, {Peter T.} and Fernandez, {Claudio O.} and David Eliezer and Markus Zweckstetter and Lashuel, {Hilal A.}",
year = "2008",
month = "6",
day = "13",
doi = "10.1074/jbc.M800747200",
language = "English",
volume = "283",
pages = "16895--16905",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "24",

}

TY - JOUR

T1 - Phosphorylation at Ser-129 but not the phosphomimics S129E/D inhibits the fibrillation of α-synuclein

AU - Paleologou, Katerina E.

AU - Schmid, Adrian W.

AU - Rospigliosi, Carla C.

AU - Kim, Hai Young

AU - Lamberto, Gonzalo R.

AU - Fredenburg, Ross A.

AU - Lansbury, Peter T.

AU - Fernandez, Claudio O.

AU - Eliezer, David

AU - Zweckstetter, Markus

AU - Lashuel, Hilal A.

PY - 2008/6/13

Y1 - 2008/6/13

N2 - α-Synuclein (α-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related α-synulceinopathies. However, whether phosphorylation promotes or inhibits α-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of α-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type α-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated α-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of α-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of α-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern α-syn aggregation and toxicity in PD and related α-synulceinopathies.

AB - α-Synuclein (α-syn) phosphorylation at serine 129 is characteristic of Parkinson disease (PD) and related α-synulceinopathies. However, whether phosphorylation promotes or inhibits α-syn aggregation and neurotoxicity in vivo remains unknown. This understanding is critical for elucidating the role of α-syn in the pathogenesis of PD and for development of therapeutic strategies for PD. To better understand the structural and molecular consequences of Ser-129 phosphorylation, we compared the biochemical, structural, and membrane binding properties of wild type α-syn to those of the phosphorylation mimics (S129E, S129D) as well as of in vitro phosphorylated α-syn using a battery of biophysical techniques. Our results demonstrate that phosphorylation at Ser-129 increases the conformational flexibility of α-syn and inhibits its fibrillogenesis in vitro but does not perturb its membrane-bound conformation. In addition, we show that the phosphorylation mimics (S129E/D) do not reproduce the effect of phosphorylation on the structural and aggregation properties of α-syn in vitro. Our findings have significant implications for current strategies to elucidate the role of phosphorylation in modulating protein structure and function in health and disease and provide novel insight into the underlying mechanisms that govern α-syn aggregation and toxicity in PD and related α-synulceinopathies.

UR - http://www.scopus.com/inward/record.url?scp=47749107973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47749107973&partnerID=8YFLogxK

U2 - 10.1074/jbc.M800747200

DO - 10.1074/jbc.M800747200

M3 - Article

C2 - 18343814

AN - SCOPUS:47749107973

VL - 283

SP - 16895

EP - 16905

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 24

ER -